DavidShermanMD

PubMed

• Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
  Tiruveedhula VVNPB, Witzigmann CM, Verma R, Kabir MS, Rott M, Schwan WR, Medina-Bielski S, Lane M, Close W, Polanowski RL, Sherman D, Monte A, Deschamps JR, Cook JM> ;Bioorg. Med. Chem.. 2013-12-15
• Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli.
  Sherman, D. J.,Okuda, S.,Denny, W. A.,Kahne, D.> ;Bioorg. Med. Chem.. 2013 Aug 15
• A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivatives.
  Kabir MS, Namjoshi OA, Verma R, Polanowski R, Krueger SM, Sherman D, Rott MA, Schwan WR, Monte A, Cook JM> ;Bioorg. Med. Chem.. 2010-06-15
• The methymycin/pikromycin pathway: a model for metabolic diversity in natural product biosynthesis.
  Kittendorf JD, Sherman DH> ;Bioorg. Med. Chem.. 2009-03-15
• The Group as a Resource: Reducing Biased Attributions for Group Success and Failure via Group Affirmation
  David Sherman, MD> ;Personality and Social Psychology Bulletin. 2007 Jul 17
• Antimicrobial effects of novel siderophores linked to beta-lactam antibiotics.
  Kline T, Fromhold M, McKennon TE, Cai S, Treiberg J, Ihle N, Sherman D, Schwan W, Hickey MJ, Warrener P, Witte PR, Brody LL, Goltry L, Barker LM, Anderson SU, Tanaka S...> ;Bioorg. Med. Chem.. 2000-01-01
• Join now to see all